Daiichi Sankyo Company, Limited (TYO:4568)
2,650.50
+48.00 (1.84%)
Apr 28, 2026, 3:30 PM JST
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 19,765 employees as of March 31, 2025. The number of employees increased by 1,039 or 5.55% compared to the previous year.
Employees
19,765
Change (1Y)
1,039
Growth (1Y)
5.55%
Revenue / Employee
103.83M JPY
Profits / Employee
15.41M JPY
Market Cap
4,860.49B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Astellas Pharma | 13,643 |
| Otsuka Holdings | 37,758 |
| Chugai Pharmaceutical | 5,104 |
| Kyowa Kirin | 5,161 |
| Ono Pharmaceutical | 4,287 |
| Santen Pharmaceutical | 3,849 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Daiichi Sankyo Company News
- 3 hours ago - Fortis Healthcare awaits Tokyo court judgement in NTK's claim against Daiichi Sankyo - Business Upturn
- 13 days ago - Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies - PRNewsWire
- 13 days ago - Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase - PRNewsWire
- 15 days ago - 4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program - Business Wire
- 27 days ago - Nuvation Bio Acquires Japan Rights For Safusidenib; Now Owns Global Clinical Development Program - Nasdaq
- 6 weeks ago - Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCs - Business Wire
- 6 weeks ago - Nikkei Rises 1.1%, Led by Shipping, Financial Stocks - WSJ
- 7 weeks ago - GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. - Business Wire